×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

GCC Kidney Stones Market

ID: MRFR/HC/51103-HCR
200 Pages
Garvit Vyas
October 2025

GCC Kidney Stones Market Research Report By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy) and By Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

GCC Kidney Stones Market Infographic
Purchase Options

GCC Kidney Stones Market Summary

As per MRFR analysis, the GCC kidney stones market size was estimated at 135.0 $ Million in 2024. The GCC kidney stones market is projected to grow from 139.91 $ Million in 2025 to 200.0 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 3.64% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The GCC kidney stones market is experiencing notable growth driven by rising incidence and technological advancements.

  • The market is witnessing a rising incidence of kidney stones, indicating a growing health concern in the region.
  • Technological advancements in treatment options are enhancing patient outcomes and driving market growth.
  • Increased public awareness and education regarding kidney stones are contributing to early diagnosis and treatment.
  • The growing prevalence of risk factors and advancements in diagnostic techniques are key drivers of the market's expansion.

Market Size & Forecast

2024 Market Size 135.0 (USD Million)
2035 Market Size 200.0 (USD Million)

Major Players

Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE)

GCC Kidney Stones Market Trends

the kidney stones market is experiencing notable developments, driven by a combination of rising prevalence rates and advancements in medical technology. In the GCC region, the incidence of kidney stones appears to be increasing, influenced by factors such as dietary habits, climate, and lifestyle choices. As healthcare systems evolve, there is a growing emphasis on early diagnosis and effective treatment options. This shift is likely to enhance patient outcomes and reduce the burden on healthcare facilities. Furthermore, the integration of innovative technologies, such as minimally invasive surgical techniques and improved imaging modalities, is transforming the landscape of treatment, making it more efficient and patient-friendly. In addition to technological advancements, public awareness campaigns are gaining traction, aiming to educate individuals about prevention strategies and the importance of hydration. These initiatives may contribute to a decrease in the incidence of kidney stones over time. Moreover, the collaboration between healthcare providers and government entities is fostering a more comprehensive approach to managing this condition. As the kidney stones market continues to evolve, stakeholders must remain vigilant in addressing emerging challenges and opportunities, ensuring that patients receive optimal care and support.

Rising Incidence of Kidney Stones

The prevalence of kidney stones in the GCC region is on the rise, attributed to various lifestyle factors. Poor dietary choices, coupled with inadequate hydration, contribute to this trend. As awareness increases, healthcare providers are focusing on preventive measures to mitigate the impact of this condition.

Technological Advancements in Treatment

Innovations in medical technology are reshaping treatment options within the kidney stones market. Minimally invasive procedures and enhanced imaging techniques are becoming more common, allowing for quicker recovery times and improved patient experiences. This trend indicates a shift towards more efficient healthcare delivery.

Increased Public Awareness and Education

Public health initiatives aimed at educating the population about kidney stones are gaining momentum. These campaigns emphasize the importance of hydration and dietary modifications, potentially leading to a decrease in new cases. As awareness grows, the overall management of kidney stones may improve.

GCC Kidney Stones Market Drivers

Increasing Healthcare Expenditure

The kidney stones market is benefiting from the rising healthcare expenditure in the GCC region. Governments and private sectors are investing more in healthcare infrastructure, which includes the treatment of kidney stones. Reports indicate that healthcare spending in GCC countries is projected to reach $100 billion by 2025, reflecting a commitment to improving health services. This increase in funding allows for better access to advanced treatment options and technologies for kidney stones. As healthcare facilities expand and upgrade their services, the kidney stones market is likely to see a surge in demand for both surgical and non-surgical treatment modalities. This trend indicates a positive outlook for market growth as more patients receive timely and effective care.

Expansion of Telemedicine Services

The kidney stones market is witnessing a transformation due to the expansion of telemedicine services in the GCC region. Telehealth platforms are increasingly being utilized to provide consultations, follow-ups, and education regarding kidney stone management. This trend is particularly beneficial in remote areas where access to specialized healthcare may be limited. By leveraging technology, healthcare providers can reach a broader audience, offering guidance on prevention and treatment options for kidney stones. The convenience of telemedicine is likely to encourage more individuals to seek help for their symptoms, thereby driving demand in the kidney stones market. As telehealth continues to evolve, it may play a pivotal role in enhancing patient engagement and improving health outcomes.

Growing Prevalence of Risk Factors

The kidney stones market is experiencing growth due to the increasing prevalence of risk factors associated with stone formation. Factors such as obesity, diabetes, and dietary habits are becoming more common in the GCC region. For instance, studies indicate that the obesity rate in GCC countries has reached approximately 35%, which is a significant contributor to the rise in kidney stones. Additionally, high consumption of processed foods and low water intake exacerbate the situation. As more individuals are diagnosed with conditions that predispose them to kidney stones, the demand for treatment options and preventive measures in the kidney stones market is likely to increase. This trend suggests a potential for market expansion as healthcare providers focus on addressing these risk factors through education and intervention.

Advancements in Diagnostic Techniques

Innovations in diagnostic techniques are playing a crucial role in the kidney stones market. Enhanced imaging technologies, such as high-resolution ultrasound and CT scans, allow for more accurate detection and characterization of kidney stones. These advancements facilitate timely diagnosis and treatment, which is essential in managing the condition effectively. In the GCC region, the adoption of these technologies is on the rise, with healthcare facilities investing in state-of-the-art equipment. This shift not only improves patient outcomes but also drives the growth of the kidney stones market as more individuals seek medical attention for their symptoms. The integration of artificial intelligence in imaging analysis further enhances diagnostic accuracy, potentially leading to earlier interventions and better management of kidney stones.

Rising Awareness of Preventive Healthcare

There is a notable increase in awareness regarding preventive healthcare measures among the population in the GCC region. Educational campaigns and health initiatives are emphasizing the importance of hydration, dietary modifications, and lifestyle changes to prevent kidney stones. This growing awareness is likely to influence consumer behavior, leading to a higher demand for preventive products and services in the kidney stones market. As individuals become more proactive about their health, they may seek out supplements, dietary plans, and regular check-ups to mitigate their risk of developing kidney stones. This shift towards preventive healthcare could significantly impact the market dynamics, fostering a culture of health consciousness that benefits both patients and healthcare providers.

Market Segment Insights

Kidney Stones Market Type Insights

The GCC Kidney Stones Market is segmented by Type, encompassing various stones that reflect specific biochemical compositions leading to their formation. Among these, Calcium Oxalate Stones are the most prevalent, accounting for a significant portion of kidney stone cases within the region. This prominence can be attributed to dietary factors, including high oxalate intake from certain fruits and vegetables, which is common in the GCC dietary practices. Uric Acid Stones also represent a notable segment, often associated with high purine diets, prominent in local cuisines.

The rising incidence of obesity and metabolic disorders in the GCC region further contributes to the formation of uric acid stones, showcasing the need for awareness and preventive strategies.

Struvite Kidney Stones, typically resulting from urinary tract infections, illustrate a unique challenge, especially in areas with high prevalence of such infections. The importance of addressing this type lies in its association with chronic health issues, necessitating improved healthcare interventions. Cystine Stones, although less common, indicate a genetic predisposition that may require tailored management strategies for affected individuals. Meanwhile, Calcium Phosphate Stones are gaining attention due to their rising incidence, often linked with renal tubular acidosis, which can be prevalent in specific demographics in the GCC.

Overall, the segmentation within the GCC Kidney Stones Market by Type reflects complex interrelations between diet, health predispositions, and environmental factors, all of which warrant tailored healthcare strategies to mitigate the impact of kidney stones in the population. The growth potential within each segment highlights opportunities for advancements in prevention, diagnosis, and treatment approaches, serving the unique needs of the GCC population as lifestyle changes evolve and awareness around kidney health improves.

Kidney Stones Market Treatment Type Insights

The Treatment Type segment of the GCC Kidney Stones Market is crucial for managing this prevalent health issue, characterized by various effective methodologies. Medications play a vital role in the initial management of kidney stones, helping to alleviate pain and facilitate stone passage, which is especially significant due to the rising incidence of kidney stones in the GCC region. Extracorporeal Shock Wave Lithotripsy (ESWL) is another prominent technique as it utilizes shock waves to break stones into smaller fragments, making it minimally invasive and popular among patients seeking faster recovery times.

Ureteroscopy provides a direct approach to remove stones from the urinary tract, gaining traction due to its effectiveness and the requirement for immediate resolution in urgent cases. Percutaneous Nephrolithotomy is significant for larger stones, offering a more invasive method but ensuring high success rates for cases that cannot be resolved through less invasive procedures. The infusion of advanced technologies within these treatment types is expected to continually enhance patient outcomes and support the market's evolution amidst increasing healthcare demands in the GCC region, which has been a focal point for healthcare reform and improvement initiatives.

Enhanced access to these treatment options is also contributing to the GCC Kidney Stones Market growth, reflecting a metamorphosis in how kidney stones are treated in the region.

Kidney Stones Market Diagnosis Insights

The Diagnosis segment of the GCC Kidney Stones Market plays a crucial role in identifying and treating this prevalent condition, which affects a considerable portion of the population in the region. Various diagnostic techniques such as Ultrasound, Intravenous Pyelography, CT scan, and X-Ray are widely utilized, each providing unique advantages in terms of accuracy, accessibility, and patient comfort. Ultrasound, for instance, is non-invasive and does not involve radiation, making it a favorable option in many clinical settings. Intravenous Pyelography holds significance for its detailed imaging of the urinary tract, assisting in discerning the location and size of stones effectively.

CT scans have gained attention for their high sensitivity and specificity, allowing for rapid diagnosis and management decisions. X-rays, while less effective for certain stone types, remain valuable for evaluating kidney function and stone location. The increasing prevalence of kidney stones in the GCC, driven by factors such as dietary habits and lifestyle, has spurred advancements in diagnostic technologies. 

This growing focus on precision in diagnosis is further amplified by the region's increased healthcare spending and the adoption of innovative medical technologies, thus enriching the overall GCC Kidney Stones Market data and statistics related to this segment.

Get more detailed insights about GCC Kidney Stones Market

Key Players and Competitive Insights

The competitive dynamics within the kidney stones market are characterized by a blend of innovation, strategic partnerships, and regional expansion. Key growth drivers include the rising prevalence of kidney stones, advancements in minimally invasive surgical techniques, and increasing healthcare expenditure across the GCC. Major players such as Boston Scientific (US), Medtronic (US), and Olympus Corporation (JP) are actively shaping the landscape through their focus on technological advancements and strategic collaborations. For instance, Boston Scientific (US) emphasizes innovation in its product offerings, particularly in the development of advanced lithotripsy devices, which enhances patient outcomes and operational efficiency.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for competitive pricing strategies, yet the influence of major companies like Medtronic (US) and Johnson & Johnson (US) remains significant, as they leverage their extensive distribution networks and brand recognition to capture market share.

In October 2025, Medtronic (US) announced a strategic partnership with a leading regional healthcare provider to enhance access to its innovative kidney stone management solutions. This collaboration is poised to improve patient care by integrating advanced technologies into local healthcare systems, thereby expanding Medtronic's footprint in the GCC. Such partnerships are crucial for navigating the complex regulatory landscape and addressing the specific needs of regional markets.

In September 2025, Olympus Corporation (JP) launched a new endoscopic system designed for the treatment of kidney stones, which incorporates AI-driven imaging technology. This development not only signifies Olympus's commitment to innovation but also positions the company to capitalize on the growing demand for precision in surgical procedures. The integration of AI into medical devices is likely to enhance surgical outcomes and streamline operational processes, thereby reinforcing Olympus's competitive edge.

In November 2025, Johnson & Johnson (US) unveiled a comprehensive digital platform aimed at improving patient engagement and education regarding kidney stone prevention and treatment. This initiative reflects a broader trend towards digitalization in healthcare, where patient-centric approaches are becoming increasingly vital. By leveraging technology to enhance patient knowledge and adherence to treatment protocols, Johnson & Johnson is likely to strengthen its market position and foster long-term customer loyalty.

As of November 2025, current trends in the kidney stones market indicate a shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise to address complex healthcare challenges. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of agility and responsiveness in meeting the dynamic needs of the market.

Key Companies in the GCC Kidney Stones Market market include

Industry Developments

The GCC Kidney Stones Market has seen significant developments recently, particularly with increased investments in healthcare technology aimed at improving treatment options. Companies like Siemens Healthineers and Boston Scientific are focusing on advanced imaging and surgical technologies to enhance kidney stone management. In September 2023, Medtronic announced a collaboration with local healthcare providers in the GCC to offer training and education on minimally invasive treatments for urolithiasis. Meanwhile, Stryker Corporation has been involved in expanding its product offerings in the region, with an emphasis on improving patient outcomes through innovative devices. 

In terms of mergers and acquisitions, no notable activity specific to the GCC Kidney Stones Market has been reported among the listed companies in recent months. However, the market has been positively impacted by a growing awareness of preventive care and lifestyle changes, leading to increased demand for effective treatment solutions. Over the past two years, the GCC has witnessed a surge in healthcare spending to address rising incidences of kidney stones, supported by government initiatives to enhance healthcare facilities across Saudi Arabia, UAE, and Qatar.

Future Outlook

GCC Kidney Stones Market Future Outlook

The Kidney Stones Market is projected to grow at a 3.64% CAGR from 2024 to 2035, driven by increasing prevalence, advancements in treatment technologies, and rising healthcare expenditure.

New opportunities lie in:

  • Development of telehealth platforms for remote consultations and follow-ups.
  • Investment in AI-driven diagnostic tools for early detection of kidney stones.
  • Expansion of minimally invasive surgical techniques to enhance patient recovery and satisfaction.

By 2035, the kidney stones market is expected to achieve substantial growth, driven by innovation and increased healthcare access.

Market Segmentation

GCC Kidney Stones Market Type Outlook

  • Calcium Oxalate Stones
  • Uric Acid
  • Struvite Kidney Stones
  • Cystine Stones
  • Calcium Phosphate Stones

GCC Kidney Stones Market Diagnosis Outlook

  • Ultrasound
  • Intravenous Pyelography
  • CT Scan
  • X-Ray
  • Others

GCC Kidney Stones Market Treatment Type Outlook

  • Medications
  • Extracorporeal Shock Wave Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithotomy

Report Scope

MARKET SIZE 2024135.0(USD Million)
MARKET SIZE 2025139.91(USD Million)
MARKET SIZE 2035200.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)3.64% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled["Boston Scientific (US)", "Medtronic (US)", "Johnson & Johnson (US)", "C.R. Bard (US)", "Cook Medical (US)", "Olympus Corporation (JP)", "Stryker Corporation (US)", "Terumo Corporation (JP)", "Karl Storz (DE)"]
Segments CoveredType, Treatment Type, Diagnosis
Key Market OpportunitiesEmergence of advanced minimally invasive treatment technologies for kidney stones.
Key Market DynamicsRising prevalence of kidney stones drives demand for advanced treatment options and innovative technologies in the GCC region.
Countries CoveredGCC

Leave a Comment

FAQs

What is the expected market size of the GCC Kidney Stones Market in 2024?

The GCC Kidney Stones Market is expected to be valued at 162.0 million USD in 2024.

What will the value of the GCC Kidney Stones Market be by 2035?

By 2035, the GCC Kidney Stones Market is projected to reach a value of 970.0 million USD.

What is the expected compound annual growth rate (CAGR) for the GCC Kidney Stones Market from 2025 to 2035?

The expected CAGR for the GCC Kidney Stones Market from 2025 to 2035 is 17.668%.

Which type of kidney stones holds the largest market share in 2024?

Calcium Oxalate Stones are valued at 60.0 million USD, making them the largest segment in 2024.

What is the projected market value for Uric Acid Stones by 2035?

The projected market value for Uric Acid Stones by 2035 is 240.0 million USD.

Who are the key players dominating the GCC Kidney Stones Market?

Major players include Siemens Healthineers, Olympus Corporation, and Stryker Corporation among others.

What is the market size for Struvite Kidney Stones in 2024?

The market size for Struvite Kidney Stones is expected to be 25.0 million USD in 2024.

How much is the GCC Kidney Stones Market for Cystine Stones expected to be worth in 2035?

The market for Cystine Stones is expected to reach 130.0 million USD by 2035.

What growth trends are emerging in the GCC Kidney Stones Market?

Key trends include increasing prevalence of kidney stones and advancements in treatment technologies.

What is the market value for Calcium Phosphate Stones in 2024?

Calcium Phosphate Stones are expected to have a market value of 15.0 million USD in 2024.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions